212 related articles for article (PubMed ID: 29258771)
1. Identification of novel small-molecule inhibitors of Zika virus infection.
Micewicz ED; Khachatoorian R; French SW; Ruchala P
Bioorg Med Chem Lett; 2018 Feb; 28(3):452-458. PubMed ID: 29258771
[TBL] [Abstract][Full Text] [Related]
2. Optimization of 1,3-disubstituted urea-based inhibitors of Zika virus infection.
Khachatoorian R; Micewicz ED; Micewicz A; French SW; Ruchala P
Bioorg Med Chem Lett; 2019 Oct; 29(20):126626. PubMed ID: 31477351
[TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
[TBL] [Abstract][Full Text] [Related]
7. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.
Telehany SM; Humby MS; McGee TD; Riley SP; Jacobs A; Rizzo RC
Biochemistry; 2020 Oct; 59(39):3709-3724. PubMed ID: 32876433
[TBL] [Abstract][Full Text] [Related]
8. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
9. Identification of Ascomycin against Zika virus infection through screening of natural product library.
Zhou L; Zhou J; Chen T; Chi X; Liu X; Pan S; Chen W; Wu T; Lin T; Zhang X; Li YP; Yang W
Antiviral Res; 2021 Dec; 196():105210. PubMed ID: 34801589
[TBL] [Abstract][Full Text] [Related]
10. Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.
Saiz JC; Oya NJ; Blázquez AB; Escribano-Romero E; Martín-Acebes MA
Viruses; 2018 Aug; 10(9):. PubMed ID: 30149598
[TBL] [Abstract][Full Text] [Related]
11. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.
Han Y; Mesplède T
Expert Opin Investig Drugs; 2018 Dec; 27(12):951-962. PubMed ID: 30430882
[TBL] [Abstract][Full Text] [Related]
12. Current Breakthroughs in Structure-based Design of Synthetic and Natural Sourced Inhibitors Against Zika Viral Targets.
Nandi S; Kaur R; Kumar M; Sharma A; Naaz A; Mandal SC
Curr Top Med Chem; 2018; 18(20):1792-1803. PubMed ID: 30465510
[TBL] [Abstract][Full Text] [Related]
13. Novel Nucleoside Analogues as Effective Antiviral Agents for Zika Virus Infections.
Bassetto M; Cima CM; Basso M; Salerno M; Schwarze F; Friese D; Bugert JJ; Brancale A
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092055
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
[TBL] [Abstract][Full Text] [Related]
16. The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus.
Cataneo AHD; Kuczera D; Koishi AC; Zanluca C; Silveira GF; Arruda TB; Suzukawa AA; Bortot LO; Dias-Baruffi M; Verri WA; Robert AW; Stimamiglio MA; Duarte Dos Santos CN; Wowk PF; Bordignon J
Sci Rep; 2019 Nov; 9(1):16348. PubMed ID: 31705028
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
de Souza AAA; Torres LR; Capobianco LRPL; de Paula VS; Cascabulho CM; Salomão K; Bonecini-Almeida MDG; Ferreira MLG; Boechat N; Pinheiro LCDS; de Souza EM
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383619
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of pinocembrin against Zika virus replication.
Lee JL; Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Jul; 167():13-24. PubMed ID: 30959074
[TBL] [Abstract][Full Text] [Related]
19. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus.
Bernatchez JA; Yang Z; Coste M; Li J; Beck S; Liu Y; Clark AE; Zhu Z; Luna LA; Sohl CD; Purse BW; Li R; Siqueira-Neto JL
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
